Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trialsEric L. Simpson, Kristian Reich, Lawrence F. Eichenfield et al.|British Journal of Dermatology|2020Cited by 377
Development of the alopecia areata scale for clinical use: Results of an academic–industry collaborative effortBrett King, Maryanne M. Senna, Natasha Atanaskova Mesinkovska et al.|Journal of the American Academy of Dermatology|2021Cited by 79